Orca Bio
Alex Kolicich is an advisor at Orca Bio. Alex has previously worked as a partner at Formation 8, an investor and advisor at Blend Labs, and an investor at Helion Energy. Alex has also served as a board observer at C2FO and as a principal at Mithril Capital Management. Prior to that, they were the PM, Vice President, Research & Trading at Clarium Capital Management. Kolicich has also been an advisor at Palantir Technologies.
Alex Kolicich received their B.SE in Software Engineering from the University of Waterloo and their MA in Economics from the University of Toronto.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.